Annals of Nutrition and Metabolism

Original Paper

Influence of Apolipoprotein E Polymorphism on Cardiovascular Risk Factors in Obese Children

Guerra A.a · Rego C.a · Castro E.M.B.b · Seixas S.c · Rocha J.c

Author affiliations

aDepartment of Pediatrics, Hospital S. João, Faculty of Medicine, bBiochemical Department, Faculty of Pharmacy, and cInstitute of Pathology and Molecular Immunology, Faculty of Sciences, University of Porto, Portugal

Keywords: Obesity, childrenApolipoprotein E polymorphismLipid profileCardiovascular risk factors

Related Articles for ""
Ann Nutr Metab 2003;47:49–54
https://doi.org/10.1159/000069275

Log in to MyKarger to check if you already have access to this title.




Forgot your password
Sign up to MyKarger

Buy

  • FullText & PDF
  • Unlimited re-access via MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more
CHF 38.00 *
EUR 35.00 *
USD 39.00 *

Select

KAB

Buy a Karger Article Bundle (KAB) and profit from a discount!


If you would like to redeem your KAB credit, please log in.

Save over 20% compared to the individual article price.

Learn more

Rent/Cloud

  • Rent for 48h to view
  • Buy Cloud Access for unlimited viewing via different devices
  • Synchronizing in the ReadCube Cloud
  • Printing and saving restrictions apply
Rental: USD 8.50
Cloud: USD 20.00

Select

Subscribe

  • Access to all articles of the subscribed year(s) guaranteed for 5 years
  • Unlimited re-access via Subscriber Login or MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

Subcription rates

Select
* The final prices may differ from the prices shown due to specifics of VAT rules.

Article / Publication Details

First-Page Preview
Abstract of Original Paper

Received: February 11, 2002
Accepted: July 08, 2002
Published online: March 27, 2003
Issue release date: March – April

Number of Print Pages: 6
Number of Figures: 0
Number of Tables: 7

ISSN: 0250-6807 (Print)
eISSN: 1421-9697 (Online)

For additional information: https://www.karger.com/ANM

Abstract

Aim: The main objective of the study was to determine whether risk factors associated with obesity are influenced by genetic variation of apolipoprotein E (ApoE). Methods: 81 obese children (mean age 9.4 ± 2.8 years) and an age-matched control group were included. Body composition, lipid profile, and glucose and insulin levels were evaluated according to international recommendations, and the blood pressure was measured by an oscillometric method. Results: The calculated frequencies of the ApoE alleles *2, *3, and *4 (0.04, 0.88 and 0.08) in obese children were similar to those of eutrophic age-matched controls (0.07, 0.82, and 0.11) and fitted the range of variation generally observed in southern European populations. Age, anthropometric parameters, body fat mass, and blood pressure were similar in E2/3, E3/3 and E4/3 genotypes. Total/high-density lipoprotein cholesterol and low-density lipoprotein/high-density lipoprotein cholesterol ratios were higher in the E4/3 group as compared with E3/3 (p < 0.01) and E2/3 (p < 0.05) groups. No differences concerning clusters of risk factors were observed among the three genotypes. No associations were found between ApoE polymorphism and glucose levels (fasting and at 2 h) and between fasting insulin levels and HOMAIR results. Higher levels of fasting and 2-hour insulin and higher HOMAIR values were significantly associated with a higher fat mass. Conclusions: ApoE polymorphism seems to influence some lipid profile abnormalities associated with obesity in childhood. However, clustering of risk factors and insulin resistance seem not to be dependent on ApoE polymorphism.

© 2003 S. Karger AG, Basel



Related Articles:

References

  1. Morrison JA, Sprecher DL, Barton BA, Waclawiw MA, Daniels SR: Overweight, fat patterning, and cardiovascular disease risk factors in black and white girls: The National Heart, Lung, and Blood Institute Growth and Health Study. J Pediatr 1999;135:458–464.
  2. Myers L, Coughlin SS, Webber LS, Srinivasan SR, Berenson GS: Prediction of adult cardiovascular multifactorial risk status from childhood risk factor levels: The Bogalusa Heart Study. Am J Epidemiol 1995;142:918–924.
    External Resources
  3. Motulsky AG: Nutrition and genetic susceptibility to common diseases. Am J Clin Nutr 1992;55(suppl):1244–1245.
  4. Grundy SM, Denke MA: Dietary influences on serum lipids and lipoproteins. J Lipid Res 1990;31:1149–1172.
    External Resources
  5. Sanghera DK, Ferrell RE, Aston CE, McAllister AE, Kamboh MI, Kimm SY: Quantitative effects of the apolipoprotein E polymorphism in a biracial sample of 9–10-year-old girls. Atherosclerosis 1996;126:35–42.
    External Resources
  6. Srinivasan SR, Ehnholm C, Elkasabany A, Berenson G: Influence of apolipoprotein E polymorphism on serum lipids and lipoprotein changes from childhood to adulthood: The Bogalusa Heart Study. Atherosclerosis 1999;143:435–443.
    External Resources
  7. Kallio MJ, Salmenpera L, Siimes MA, Perheentupa J, Gylling H, Miettienen TA: The apolipoprotein E phenotype has a strong influence on tracking of serum cholesterol and lipoprotein levels in children: A follow-up study from birth to the age of 11 years. Pediatr Res 1998;43:381–385.
  8. Corbo RM, Scacchi R, Mureddu L, Mulas G, Alfano G: Apolipoprotein E polymorphism in Italy investigated in a native plasma by a simple polyacrylamide gel isoelectric focusing technique: Comparison with frequency data of other European populations. Ann Hum Genet 1995;59:197–209.
    External Resources
  9. Hallman DM, Boerwinkle E, Saha N, Sandholzer C, Menzel HJ, Csázár A, Utermann G: The apolipoprotein E polymorphism: A comparison of allele frequencies and effects in nine populations. Am J Hum Genet 1991;49:338–349.
    External Resources
  10. Kamboh MI, Sepehrnia B, Ferrell RE: Genetic studies of human apolipoproteins. VI. Common polymorphism of apolipoprotein E in blacks. Dis Markers 1989;7:49–55.
    External Resources
  11. Utermann G: Apolipoprotein E polymorphism in health and disease. Am Heart J 1987;113:433–440.
    External Resources
  12. Parlier G, Thomas G, Bereziat G, Fontaine JL, Girardet JP: Relation of apolipoprotein E polymorphism to lipid metabolism in obese children. Pediatr Res 1997;41:682–685.
  13. Sing CF, Davignon J: Role of apolipoprotein E polymorphism in determining normal plasma and lipoprotein variation. Am J Hum Genet 1985;37:268–285.
    External Resources
  14. Hamill PV, Drizd TA, Johnson CL, Reed RB, Roche AF, Moore WM: Physical growth: National Center for Health Statistics percentiles. Am J Clin Nutr 1979;32:607–629.
    External Resources
  15. Frisancho AR: Anthropometric Standards for the Assessment of Growth and Nutritional Status, ed 4. Ann Arbor, University of Michigan Press, 1993.
  16. Lee J, Kolouel N, Hinds W: Relative merits of the weight-corrected-for-height indices. Am J Clin Nutr 1981;34:2521–2529.
  17. Abu Khaled M, McCutcheon MJ, Reddy S, Pearman PL, Hunter GR, Weinsier RL: Electrical impedance in assessing human body composition: The BIA method. Am J Clin Nutr 1988;47:789–792.
    External Resources
  18. Alain CC, Poon LS, Chan CSG, Richmond W, Fu PC: Enzymatic determination of total serum cholesterol. Clin Chem 1974;20:470–475.
    External Resources
  19. Flegg HM: An investigation of the determination of serum cholesterol by an enzymatic method. Am Clin Biochem 1973;10:79.
  20. Manual of Laboratory Operations: Lipid Research Clinics Program. Lipid and Lipoprotein Analysis. Bethesda, National Institutes of Health, 1974, vol 1, p 75.
  21. Lindgren FT, Jensen LC, Hatch FT: The isolation and quantitative analysis of serum lipoprotein; in Nelson GJ (ed): Blood Lipid and Lipoproteins. New York, Wiley, 1972, pp 181–274.
  22. Wenham PR, Price WH, Blandell G: Apolipoprotein E genotyping by one-stage PCR. Lancet 1991;337:1158–1159.
  23. Alberti KG, Zimmet PZ, for the WHO Consultation: Definition, diagnosis and classification of diabetes mellitus and its complications. 1. Diagnosis and classification of diabetes mellitus: Provisional report of a WHO consultation. Diabet Med 1998;15:539–553.
    External Resources
  24. Haffner SM, Miettinen H, Stern MP: The homeostasis model in the San Antonio Heart Study. Diabetes Care 1997;20:1087–1092.
    External Resources
  25. Frohlich ED, Grim C, Labarthe DR, Maxwell MH, Perloff D, Weidman WH: Recommendations for human blood pressure determination by sphygmomanometers: Report of a special task force appointed by the Steering Committee of the American Heart Association. Circulation 1988;77:501–514.
  26. Report of the Second Task Force on Blood Pressure Control in Children. Pediatrics 1987;79:1–25.
    External Resources
  27. Schneider S, Kueffer JM, Roessli D, Excoffier L: Arlequin ver. 1.1: A Software for Population Genetic Data Analysis. Geneva, University of Geneva, 1997.
  28. Seixas S, Trovoada MJ, Rocha J: Haplotype analysis of the apolipoprotein E (APOE) and apolipoprotein C1 (APOC1) loci in Portugal and S. Tomé e Príncipe (Gulf of Guinea): Linkage disequilibrium evidence that apolipoprotein E*4 is the ancestral APOE allele. Hum Biol 1999;71:1001–1008.
    External Resources
  29. Guerra A, Rego C, Castro EMB, Seixas S, Rocha J: Association between apolipoprotein E phenotype and lipid profile and adiposity in Portuguese children. Atherosclerosis 2000;151:153.
  30. Assman G, Schmitz G, Menzel HJ, Schulte H: Apolipoprotein E polymorphism and hyperlipidemia. Clin Chem 1984;30:641–643.
    External Resources
  31. Fumeron F, Rigaud D, Bertiere MC, Bardon S, Dely C, Apfelbaum M: Association of apolipoprotein ε4 allele with hypertriglyceridemia in obesity. Clin Genet 1988;34:258–264.
    External Resources
  32. National Cholesterol Education Program (NCEP): Highlights of the report of the expert panel on blood cholesterol levels in children and adolescents. Pediatrics 1992;89:495–501.
  33. Bellù R, Ortisi MT, Scaglioni S, Agostoni C, Salanitri VS, Riva E, Giovannini M: Lipid and apoprotein A-I and B levels in obese school-age children: Results of a study in the Milan area. J Pediatr Gastroenterol Nutr 1993;16:446–450.
    External Resources
  34. Kesaniemi YA, Ehnholm C, Miettinen TA: Intestinal cholesterol absorption efficiency in man related to apoprotein E phenotype. J Clin Invest 1987;80:578–581.
    External Resources
  35. Miettinen TA, Gylling H, Vanhanen H, Ollus A: Cholesterol absorption, elimination, and synthesis related to low-density lipoprotein kinetics during varying fat intake in men with different apolipoprotein E phenotypes. Arterioscler Thromb 1992;12:1044–1052.
    External Resources
  36. Gylling H, Miettinen TA: Cholesterol absorption and synthesis related to low density lipoprotein metabolism during varying cholesterol intake in men with different apolipoprotein E phenotypes. J Lipid Res 1992;33:1361–1371.
    External Resources
  37. Szalai C, Czinner A, Császár A: Influence of apolipoprotein E genotypes on serum lipid parameters in a biracial sample of children. Eur J Pediatr 2000;159:257–260.
    External Resources
  38. Srinivasan SR, Ehnholm C, Wattigney WA, Bao W, Berenson G: The relation of the apolipoprotein E polymorphism to multiple cardiovascular risk in children: The Bogalusa Heart Study. Atherosclerosis 1996;123:33–42.
    External Resources
  39. Sveger T, Flodmark CE, Fex G, Henningsen NC: Apolipoproteins A-I and B in obese children. J Pediatr Gastroenterol Nutr 1989;9:497–501.
    External Resources
  40. Dahlström S, Viikari J, Akerblom HK, Solakivi-Jaakkola T, Uhari M, Dahl M, Lahde PL, Pesonen E, Pietikainen M, Suoninen P, et al: Atherosclerosis precursors in Finnish children and adolescents. II. Height, weight, body mass index, and skinfolds and their correlation to metabolic variables. Acta Paediatr Scand Suppl 1985;318:65–78.
  41. Guerra AJM, Rego C, Castro EMB, Rodrigues P, Silva D, Lourenço S, Bicho M, Carvalho Guerra F, Teixeira Santos N: Estudo prospectivo referente aos principais factores de risco de patologia cardiovascular desde a infância e até à adolescência. Acta Paediatr Port 1997;28:297–306.
  42. Srinivasan SR, Ehnholm C, Elkasabany A, Berenson GS: Apolipoprotein E polymorphism modulates the association between obesity and dyslipidemias during adulthood: The Bogalusa Heart Study. Metabolism 2001;50:696–702.
  43. Srinivasan SR, Ehnholm C, Elkasabany A, Berenson G: Apolipoprotein E polymorphism and its association with serum lipoprotein concentration in black versus white children: The Bogalusa Heart Study. Metabolism 1993;42:381–386.
    External Resources
  44. Mueller WH, Joos SK, Hanis CL, Zalaveta AN, Eichner J, Schull WJ: The Diabetes Alert Study: Growth, fatness, and fat patterning, adolescence through adulthood in Mexican Americans. Am J Phys Anthropol 1984;64:389–399.
  45. Kissebah AH, Vydelingum N, Murray R, Evans DJ, Hartz AJ, Kalkhoff RK, Adams PW: Relation of body fat distribution to metabolic complications of obesity. J Clin Endocrinol Metab 1982;54:254–260.
    External Resources
  46. Legido A, Sarria A, Bueno M, Garagorri J, Fleta J, Ramos F, Abos MD, Perez-Gonzalez J: Relationship of body fat distribution to metabolic complications in obese prepubertal boys: Gender related differences. Acta Paediatr Scand 1989;78:440–446.
  47. Shiwaco K, Gao TQ, Hojo N, Fukushima T, Yamane Y: Low levels of serum cholesterol and systolic blood pressure in Japanese with apolipoprotein E2/3 genotype. Clin Chim Acta 1999;284:15–23.
    External Resources

Article / Publication Details

First-Page Preview
Abstract of Original Paper

Received: February 11, 2002
Accepted: July 08, 2002
Published online: March 27, 2003
Issue release date: March – April

Number of Print Pages: 6
Number of Figures: 0
Number of Tables: 7

ISSN: 0250-6807 (Print)
eISSN: 1421-9697 (Online)

For additional information: https://www.karger.com/ANM

Copyright / Drug Dosage / Disclaimer

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

Article Tools
Article Details

2003, Vol.47, No. 2

March – April

Article

Recommend This
TOP